FDA Approves First Treatment for Eosinophilic Esophagitis, a Chronic Immune Disorder. Today, the U.S. Food and Drug Administration approved Dupixent (dupilumab) to...
dupilumab injection
read more
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
FDA Approves First Treatment for Eosinophilic Esophagitis, a Chronic Immune Disorder. Today, the U.S. Food and Drug Administration approved Dupixent (dupilumab) to...
Apremilast is indicated in the United States for the treatment of adults with active psoriatic arthritis, adult patients with plaque psoriasis who are candidates for...